Boston, United States
From innovation to impact: understand leading and emerging obesity therapeutics that are transforming lives and reshaping global wellness
That’s a Wrap! Thank You for Joining Us
Obesity Science & Innovation 2025 may have concluded, but the mission to revolutionize obesity care is just getting started!
We’re thrilled you were part of our inaugural event—your energy and engagement made it all possible. We hope you left inspired, empowered, and ready to make a lasting impact.
But why stop here? The journey continues!
Be the first to know about Obesity Science & Innovation 2026. Sign up now for exclusive updates, insider content, and early access to registration for next year’s event. Together, we’ll keep driving innovation forward!
Stay in the Loop
Speakers that Took the Stage at Obesity Science & Innovation 2025
The speaker line-up features the game-changers in obesity science. From metabolic researchers to digital health pioneers, get direct access to the voices shaping tomorrow’s breakthroughs—today.
A Snapshot of the 2025 Agenda
GLP-1 CLINICAL HIGHLIGHTS
Exploring updates from leading GLP-1, dual- and tri-agonist clinical trials, across peptide and small molecule drug modalities.
ENERGY EXPENDITURE THERAPEUTICS
Discovering the latest approaches to modulate energy expenditure, including mitochondrial uncouplers and browning agents.
BIOLOGY & TRANSLATION
Diving into the complex biology of obesity, including the shaping of translational strategies to accelerate clinical development of therapeutics.
MAINTENANCE INNOVATION
Highlighting approaches to enhance patient adherence and weight-loss maintenance, including development of oral formulations and strategies for muscle mass retention.
BEYOND GLP-1 FRONTIERS
Showcasing next generation modalities and approaches in obesity therapeutics, hear from emerging early-stage innovators who are looking at solutions beyond GLP-1, such as inflammasome inhibitors, β2AR and cannabinoid receptor agonists
RNA & GENE THERAPY
Exploring gene therapy and RNA-based approaches for obesity, including siRNA, non-coding RNA and editing technologies.
Engage Qualified Decision-Makers Across the Obesity Therapeutics Landscape!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.
To learn more about sponsorship opportunities, contact Roshni Shah: